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ABSTRACT
Purpose: To evaluate in vitro and in vivo neuromuscular blockade produced by rocuronium in rats treated with Phenobarbital and
to determine cytochrome P450 and cytochrome b5 concentrations in hepatic microsomes. Methods: Thirty rats were included in
the study and distributed into 6 groups of 5 animals each.  Rats were treated for seven days with phenobarbital (20 mg/kg) and the
following parameters were evaluated:  1) the amplitude of muscle response in the preparation of rats exposed to phenobarbital; 2)
rocuronium effect on rat preparation exposed or not to phenobarbital; 3) concentrations of cytochrome P450 and cytochrome b5
in hepatic microsomes isolated from rats exposed or not to phenobarbital.  The concentration and dose of rocuronium used in vitro
and in vivo experiments were 4 µg/mL and 0,6 mg/kg, respectively. Results: Phenobarbital in vitro and in vivo did not alter the
amplitude of muscle response. The neuromuscular blockade in vitro produced by rocuronium was significantly different (p=0.019)
between exposed (20%) and not exposed (60%) rats; the blockade in vivo was significantly greater (p=0.0081) in treated rats
(93.4%). The enzymatic concentrations were significantly greater in rats exposed to phenobarbital. Conclusions: Phenobarbital
alone did not compromise neuromuscular transmission. It produced enzymatic induction, and neuromuscular blockade in vivo
produced by rocuronium was potentiated by phenobarbital.
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RESUMO
Objetivo: Avaliar in vitro e in vivo o bloqueio neuromuscular produzido pelo rocurônio em ratos tratados com fenobarbital e
determinar as concentrações de citocromo P450 e b5 em microssomos hepáticos. Métodos: Trinta ratos foram incluídos no
estudo e distribuídos em seis grupos de cinco animais cada. Ratos foram tratados por sete dias com fenobarbital (20 mg/kg) e
avaliou-se: 1) amplitude das respostas musculares em preparação de ratos expostos ao fenobarbital; 2) o efeito do rocurônio em
preparações de ratos expostos ou não ao fenobarbital; 3) as concentrações de citocromo P450 e b5 em microssomos isolados de
fígados dos ratos expostos ou não ao fenobarbital. A concentração e dose de rocurônio utilizadas nos experimentos in vitro e in
vivo foram respectivamente de 4 µg/mL e  0,6 mg/kg. Resultados: In vitro e in vivo, o fenobarbital não alterou a amplitude das
respostas musculares. In vitro, o bloqueio produzido pelo rocurônio foi significativamente diferente (p=0.019) entre expostos
(20%) e não expostos (60%); in vivo o bloqueio foi significativamente maior (p=0.0081) nos ratos tratados (93,4%). As concentrações
enzimáticas foram significativamente maiores nos ratos expostos ao fenobarbital. Conclusões: O fenobarbital isoladamente não
comprometeu a transmissão neuromuscular. Ocasionou indução enzimática, e in vivo o bloqueio com o rocurônio foi potencializado
pelo fenobarbital.
Descritores: Fenobarbital. Bloqueadores Neuromusculares. Ratos.
1 Research performed at Laboratory of Neuromuscular Junction, Department of Pharmacology, State University of Campinas (UNICAMP), São
Paulo, Brazil.
Braga AFA et al
344  -  Acta Cirúrgica Brasileira - Vol. 23 (4) 2008
Introduction
Pharmacokinetic and pharmacodynamic characteris-
tics of neuromuscular blocking agents, can be modified by drugs
used in periods pre and post-operatory. Among these drugs are
local anesthetics, volatile anesthetic agents, antibiotics
aminoglycosides, anticonvulsants, antiarrhythmic, magnesium,
lithium, calcium channel blockers and others1-12. Although count-
less studies have been accomplished to investigate
anticonvulsants effects in the neuromuscular transmission and
its interaction with neuromuscular blocking, the results are con-
tradictory6-15.
The study accomplished in vitro and in vivo, has for
objective to evaluate in rats treated for seven days with phe-
nobarbital: the effect in the neuromuscular transmission and its
influence in the neuromuscular blockade produced by the
rocuronium; as well as to determine the cytochrome P450 and
b5 concentrations in hepatic microsomes.
Methods
It treats of an experimental in vitro and in vivo study
and the procedures used were in agreement with the Ethical
Principles for Animal Research established by Brazilian Col-
lege for Animal Experimentation (COBEA) and were approved
by the institutional Committee for Ethics in Animal Research
(State University of Campinas - UNICAMP) - protocol nº 862-2.
Were used male rats of Wistar lineage, with weight among 180 - 250g.
The animals were treated for seven days with phenobarbital
(20 mg/kg) by the gavage method, maintained in cages, in con-
trolled temperature and illumination (12-h light-dark cycle) and
they received water and ration ad libitum.
Study of muscular responses
For in vitro study was used the preparation of rat
phrenic nerve-hemidiaphragm (n=15). The animals under an-
esthesia with urethane (1,2mg/kg, through intraperitoneal route),
were sacrificed in the eighth day after treatment with phenobar-
bital, being followed by the section of neck vessels, and the
preparation was set up in agreement with the technique described
by Bulbring16. The preparation was suspended under a constant
tension of 5g in a 40ml organ bath containing aerated (95%O2 -
5%CO2) Tyrode solution (pH 7.4, 37°C) of the following com-
position (mM):  NaCl 137; KCl 2,7; CaCl2 1,8; NaHCO3 11,9;
MgCl2 0,25; NaH2PO4 0,3 and glucose 11. The nerve was placed
over platinum probes connected to a Grass S48 stimulator. The
diaphragm was held by its tendinous portion under constant
tension through a wire connected to a Load Cell BG50 GMS
isometric transducer. The diaphragm was submitted to an indi-
rect stimulation frequency of 0.1 Hz lasting 0.2msec and the
tension variations produced by diaphragmatic contractions were
recorded by a Gould RS 3400 physiographer.
For in vivo study (n=15) the sciatic external popliteal
nerve - tibialis anterior muscle preparation, was set up accord-
ing to technique proposed by Leeuwin and Wolters17. The rats
were anesthetized with urethane (1,2 mg/kg), submitted to tra-
cheostomy and maintained in ventilation mechanics with Hugo
Basile respirator (mod. 7025), regulated to maintain current
volume of 1,2 mL/kg of corporal weight and breathing frequency
of 70 movements/min. Tibialis anterior muscle tendon and sci-
atic nerve were dissectioned, sectioned and accomplished for
the member fixation to a cork base. Tendon of tibialis anterior
muscle was connected to an isometric transducer (BG 50g) and
this to the physiographer (GOULD RS 3400). The sciatic nerve
distal stump was stimulated (stimulator grass S48) through elec-
trodes connected to it, being used supramaximal stimulation of
0,2 ms of duration and frequency of 0,5 Hz. After the registra-
tion of the controls answer and the verification of the perfect
state of the preparation, rocuronium was injected in the penian
vein. In the preparations in vitro and in vivo were appraised: 1)
amplitude of the muscular answers in preparation of rats previ-
ously exposed to phenobarbital; 2) the rocuronium effect in the
muscular answers in preparations of rats previously exposed or
not to phenobarbital.
In the studies in vitro and in vivo the concentration
and the dose used of rocuronium were of 4µg/mL and 0,6mg/
kg, respectively. The muscular answers to the indirect stimula-
tion were registered and evaluated before and 60 minutes after
the injection of the rocuronium.
Study of cytochrome P450 and b5 concentrations
For the determination of cytochrome P450 and b5 con-
centrations in the hepatic microsomes, were used livers extracted
from rats exposed previously to phenobarbital, used for in vitro
and in vivo muscular responses study. It was constituted a group
control (n=5) that just received saline solution for 7 days. It
was realized the following procedure: exhibition of the liver
after ventral incision; with a catheter was injected 50 mL of
physiologic solution NaCl 0,9% without heparin in the heart
ventricle, until the liver to obtain a whitish coloration, when it
was extracted and frozen in liquid nitrogen. Were isolated he-
patic microsomes obtained from individual livers. Tissues were
hand homogenized with potassium phosphate buffer that were
centrifuged at 10000 x g for 20 minutes (Centrifuge Beckman
Avanti J-20 XPI). The supernatant was collected and
ultracentrifuged at 100000 x g for 1 hour. Microsomes were
stored in freezer to 80ºC for subsequent dosage of total pro-
teins, where Bradford’s method colorimeter was used (1976)
with BSA as standard. The specific concentrations of cyto-
chrome P450 and b5 were determinated using b5 concentration
with NADH (1mM) as reducer, and the concentration of P450
with DTN (2mM) as reducer and CO (carbon monoxide) as
ligand. For analysis a plate spectrophotometer was used (Biotek
Powerwave 2). Cytochromes concentrations were calculated
according to Lambert-Beer formula (A / C.L.İ), and related with
the concentration of total proteins of the microsomes sample.
Where:
A = delta absorbance
E = specific absorbance: P450 = 91 / mM cm and b5 = 112 / mM cm;
L = cuvette optical track, cm;
C = concentration of microsomal proteins (mg protein/mL).
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Statistical analysis
The results were expressed in averages and standard
deviations. Amplitude of muscular responses was compared
before and 60 minutes after drugs administration. The concen-
trations of P450 and b5 obtained in liver of exposed rats to
phenobarbital were compared with the one of the control group
(saline solution). It was used test t Student, being assumed sig-
nificance level of 5% (Į  = 5%). The power of the test was cal-
culated and it was obtained ȕ >20% (power > 80%).
Results
In the experiments in vitro and in vivo, there were in-
significant alterations in the amplitude of muscular responses
to indirect stimulation, in the rats previously exposed to phe-
nobarbital (Figure 1).
FIGURE 1 - Muscular responses to indirect stimulation of in vitro
(n=5) phrenic nerve-diaphragm preparation (upper tracing) and of in
vivo (n=5) sciatic nerve-tibialis anterior muscle preparation (lower trac-
ing) of rats previously exposed to phenobarbital (20mg/kg). A = stimu-
lation beginning; B = 60 minutes of stimulation
The neuromuscular blockade produced by rocuronium
in diaphragm of rats not exposed to phenobarbital was of
(69,70% ± 10,10%), with significant difference (p=0.019) in
relation to the observed in the preparations of exposed rats to
phenobarbital (20,0% ± 7,82%).The amplitude of muscular re-
sponses at 60 minutes after the addition of rocuronium were
40%  and 80% in the preparation not exposed and exposed to
Phenobarbital, respectively (Figure 2).
FIGURE 2 - Effect of rocuronium (4µg/mL) in muscular responses to
indirect stimulation of in vitro phrenic nerve-diaphragm preparation
of rats not exposed (n=5) (upper tracing-neuromuscular blockade of
60%) and previously exposed (n=5) to phenobarbital - 20mg/kg (lower
tracing-neuromuscular blockade of 20%)). A = stimulation beginning;
B = rocuronium addition; C = 60 minutes of stimulation
In experiments in vivo, accomplished in sciatic exter-
nal popliteal nerve - tibialis anterior muscle preparation, the
blockade produced by rocuronium (93.4 ± 4.21%)  was signifi-
cantly larger (p=0.0081) in rats exposed to phenobarbital, in
relation to the observed in  not exposed (66.7± 6,92%). The
amplitude of muscular responses at 60 minutes after the addi-
tion of rocuronium were 33.3% and 6.6% in the preparations
not exposed and exposed to Phenobarbital. Respectively (Fig-
ure 3).
FIGURE 3 - Effect of rocuronium (0,6mg/kg) in muscular in vivo
responses to indirect stimulation in sciatic nerve - tibialis anterior muscle
preparation of rats not exposed (n=5) (upper tracing-neuromuscular
blockade of 66.7%) and previously exposed (n=5) to phenobarbital -
20mg/kg (lower tracing-neuromuscular blockade of 93.4%). A = stimu-
lation beginning; B = rocuronium addition; C = 60 minutes of stimula-
tion
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Cytochromes P450 and b5 concentrations in hepatic
microsomes in the control group (saline solution) were 0,43
and 0,45 nmol/mg protein, respectively. In the rats exposed to
phenobarbital cytochromes P450 and b5 concentrations were,
respectively 0,69 and 0,62 nmol/mg protein, with significant
difference (p=0.022) in relationship observed in the control
group.
Discussion
Although exists many studies that describe interaction
among anticonvulsants and neuromuscular blocking agents there
is not in the literature works that show the influence of  phe-
nobarbital in the blockade produced by the different neuromus-
cular blocking agents, with consequent modification of phar-
macodynamics and pharmacokinetics properties of these agents.
Phenobarbital is a long-acting barbiturate, indicated
as hypnotic or sedative in the insomnia treatment, preoperative
mitigation and at focal and generalized tonic-clonic convulsive
emergencies.  Its mechanism is not due just to its interaction
with GABA, being probable that can also act when inhibiting
the excitatory synaptic answers. Additionally it affects mem-
branes excitability through an action on the voltage-dependent
sodium channels, that transport current into the cell, necessary
for generation of the action potential18.
In general, anticonvulsants, by itselves can act in neu-
romuscular junction, to modify or even not to interfere with the
pharmacodynamics and pharmacokinetics properties of neuro-
muscular blocking agents6-15,19-21.
Aldernice and Trommer21, studied the effects of dif-
ferent anticonvulsants in frog neuromuscular junction, and they
observed that these drugs perform different action mechanisms
in relation to nervous terminal acetylcholine liberation. Phe-
nobarbital, unlike carbamazepine, increases the neurotransmit-
ter release, it reduces the amplitude of the miniature end-plate
potentials without however to alter the amplitude of the end-
plate potentials.
Among anticonvulsants adverse effects, it is frequent
muscular weakness, that can be result of the spontaneous de-
crease or evoked quantal release of acetylcholine19,21.
Resistance to neuromuscular blocking agents it is not
clearly elucidated. The aetiology of this interaction seems to be
multifactorial and some possible mechanisms can be involved:
enzymatic induction with increase of the clearance and hepatic
metabolism; increase in alpha-1-Glicoprotein acid concentra-
tion resulting of larger protein connection, smaller fraction free
from cationic drugs and alteration in the distribution. In the
neuromuscular junction, the interaction can be due to the ac-
tion in the nervous terminal, in the synaptic cleft or in the post-
synaptic membrane, with consequent alteration in the nerve
action potential, in the synthesis, liberation or enzymatic hy-
drolysis of acetylcholine, in the calcium efflux, or even for al-
teration in the number and in the sensibility of the nicotinic
receivers, besides could cause no competitive ionic channels
blockade6-7,19,25.
Exist evidences that the resistance to neuromuscular
blocking agents, particularly aminosteroids, observed in chronic
patients treated with anticonvulsants, be due to a larger hepatic
metabolism, consequent to the enzymatic induction with in-
creased inactivation and elimination of these drugs6,22,25.
Differently of the observed in anticonvulsants chronic
exposition, experimental studies accomplished in animals and
in humans clinical assays, showed neuromuscular blockade po-
tentiated for the acute administration of several anticonvulsants
drugs9,11-13. Potentiation of pre-existent neuromuscular block-
ade, caused by anticonvulsant acute administration can be at-
tributed to the fact of these drugs compete with neuromuscular
blocking agents moving them from the plasmatic proteins stimu-
lation site with consequent increase of the free active fraction12.
Other mechanisms were described in the attempt of explaining
this potentiation, having been observed that some anti-epilep-
tic drugs exercise effects pre- and post-junctional blockade, sta-
bilizer of neuronal membrane altering the transmembrane flow
of íons sodium, potassium and calcium, besides reducing ace-
tylcholine synthesis and liberation9,11,19.
Several studies describe larger resistance to neuromus-
cular blocking agents in animals and patients chronic exposed
to anticonvulsivantes6-8,10,11,20,24,26. In this study, however, was
observed that phenobarbital in the employed dose, did not po-
tentiated the neuromuscular blockade  produced by rocuronium
in the preparations in vitro, and it potentiated the blockade in
the experiments in vivo. This findings is associated with the
enzymatic induction evidenced by the increase of cytochromes
P450 and b5 reductase. The attempt to extrapolate and corre-
late the results obtained experimentally with the clinical pic-
ture is a difficult task but the knowledge of  mechanism of in-
teraction between anticonvulsants and neuromuscular blockers
by the anesthesiologist has an important role in patient care,
emphasizing the need to monitor neuromuscular transmission
when neuromuscular blockers and anticonvulsants are concomi-
tantly used.
Conclusion
Phenobarbital alone did not compromise neuromus-
cular transmission. It produced enzymatic induction, and neu-
romuscular blockade in vivo produced by rocuronium was po-
tentiated by phenobarbital.
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